-
cds.ahrq.gov/sites/default/files/cds/artifact/127731/ASPIRE_ExerciseGuidanceForFallPrevention_Flow_0.pdf
June 01, 2022 - Yes
NoPatients 65+ Not qualified for
recommendation
Yes
No
Fall Risk Assessment
Resulted with At
-
cds.ahrq.gov/sites/default/files/cds/artifact/476/Pilot%20Site%20Training%20for%20Pain%20Management%20Summary%20CDS_for%20Repository.pdf
September 21, 2018 - making
▪ Provides an opportunity to identify errors in the patient record
▪ May shed new light on how assessment … Morphine Milligram Equivalent (MME)
– Flag if result is greater than or equal to 50: “Most recent MME assessment … most recent MME is greater than or equal to 50: “Absence
of Naloxone medication and most recent MME assessment
-
cds.ahrq.gov/sites/default/files/cds/artifact/476/Pilot%20Site%20Training%20for%20Pain%20Management%20Summary%20CDS_for%20Repository_0.pdf
September 21, 2018 - making
▪ Provides an opportunity to identify errors in the patient record
▪ May shed new light on how assessment … Morphine Milligram Equivalent (MME)
– Flag if result is greater than or equal to 50: “Most recent MME assessment … most recent MME is greater than or equal to 50: “Absence
of Naloxone medication and most recent MME assessment
-
cds.ahrq.gov/sites/default/files/cds/artifact/476/2024_CDS_Connect_IG_Pain_Management_Summary.pdf
January 01, 2024 - Patient’s pain assessment data, including the name of the assessment tool, the
score, and the date of … the assessment. … Note that the assessment tools expressed in
this artifact are those that were implemented in the pilot … tool, and assessment dates for the past year.
6. … ” Category heading in the summary that groups together pain intensity and multidimensional
assessment
-
cds.ahrq.gov/sites/default/files/cds/artifact/476/ImplementationGuidePainManagementSummary50810012018.pdf
December 01, 2018 - Patient’s pain assessment data including the score and date of the assessment. … (Note that the assessment tools expressed in this artifact are specific to the
tools implemented in … Intervention “Pain
Assessment”
Category heading in the summary that groups together pain intensity … and multi-
dimensional assessment scores. … Intervention “Wong-Baker
FACES
Assessment”
A pain intensity rating tool that enables patients to
-
cds.ahrq.gov/sites/default/files/cds/artifact/476/Implementation_Guide_Pain_Management_Summary_1.pdf
September 01, 2022 - Patient’s pain assessment data including the name of the assessment tool, the
score, and the date of … the assessment. … (Note that the assessment tools expressed in
this artifact are those that were implemented in the pilot … (score, interpretation, date)
• PEG Assessment (question response and total score, date)
• STarT … multidimensional
assessment scores.
-
cds.ahrq.gov/sites/default/files/cds/artifact/476/Implementation_Guide_Pain_Management_Summary.pdf
September 01, 2021 - Patient’s pain assessment data including the name of the assessment tool, the
score, and the date of … the assessment. … (Note that the assessment tools expressed in
this artifact are those that were implemented in the pilot … (score, interpretation, date)
• PEG Assessment (question response and total score, date)
• STarT … Intervention “Wong-Baker
FACES
Assessment”
A pain intensity rating tool that enables patients to
-
cds.ahrq.gov/sites/default/files/cds/artifact/476/2023_CDS_Connect_IG_Pain_Management_Summary.pdf
January 01, 2023 - Patient’s pain assessment data, including the name of the assessment tool, the
score, and the date of … the assessment. … Note that the assessment tools expressed in
this artifact are those that were implemented in the pilot … (score, interpretation, date)
• PEG Assessment (question response and total score, date)
• STarT … ” Category heading in the summary that groups together pain intensity and multidimensional
assessment
-
cds.ahrq.gov/sites/default/files/cds/artifact/476/ImplementationGuidePainManagementSummary508_with%202020%20updates%202.pdf
May 01, 2020 - Patient’s pain assessment data including the score and date of the assessment. … (Note that the assessment tools expressed in this artifact are specific to the
tools implemented in … (score, interpretation, date)
• PEG Assessment (question response and total score, date)
• STarT … Intervention “Wong-Baker
FACES
Assessment”
A pain intensity rating tool that enables patients to … Intervention “Risk
assessments
relevant to pain
management”
A variety of risk assessment tools
-
cds.ahrq.gov/sites/default/files/AHRQ_Final_Report_2021.pdf
January 01, 2021 - CVD and Colorectal
Cancer
No N/A No Yes
CMS’s Million Hearts® Model
Longitudinal ASCVD Risk
Assessment … Baseline 10-
Year ASCVD Risk
No N/A Yes Yes
CMS’s Million Hearts® Model
Longitudinal ASCVD Risk
Assessment … for Shared
Decision Making
No N/A No Yes
CMS’s Million Hearts® Model
Longitudinal ASCVD Risk
Assessment … https://cds.ahrq.gov/cdsconnect/artifact/cmss-million-heartsr-model-longitudinal-ascvd-risk-assessment-tool-shared … https://cds.ahrq.gov/cdsconnect/artifact/cmss-million-heartsr-model-longitudinal-ascvd-risk-assessment-tool-shared
-
cds.ahrq.gov/sites/default/files/cds/artifact/476/CDS%20Pain%20Management%20Summary%20Quick%20Start%20Guide_final.pdf
June 14, 2018 - CDS Repository Working Group Charter
CDS Pain Management Summary Quick Start Guide
The Pain Management Summary displays relevant patient-centered data to inform pain management decisions.
It includes concepts outlined in the CDC Guideline for Prescribing Opioids for Chronic Pain.
To View the Pain Man…
-
cds.ahrq.gov/sites/default/files/cds/artifact/476/CDS%20Pain%20Management%20Summary%20Quick%20Start%20Guide_final_1.pdf
June 14, 2018 - CDS Repository Working Group Charter
CDS Pain Management Summary Quick Start Guide
The Pain Management Summary displays relevant patient-centered data to inform pain management decisions.
It includes concepts outlined in the CDC Guideline for Prescribing Opioids for Chronic Pain.
To View the Pain Man…
-
cds.ahrq.gov/sites/default/files/AHRQ_Final_Report_2019.pdf
January 01, 2019 - calculation of a 10-year ASCVD risk score (i.e., CMS’s® Million Hearts Model
Longitudinal ASCVD Risk Assessment … -Year
ASCVD Risk
AHRQ Structured 02/1/2018
CMS’s Million Hearts® Model Longitudinal
ASCVD Risk Assessment … https://cds.ahrq.gov/cdsconnect/artifact/mental-health-suicide-risk-assessment-documentation-template … lowest-effective-dose
https://cds.ahrq.gov/cdsconnect/artifact/recommendation-7-opioid-therapy-risk-assessment … https://cds.ahrq.gov/cdsconnect/artifact/recommendation-7-opioid-therapy-risk-assessment
https://cds.ahrq.gov
-
cds.ahrq.gov/sites/default/files/cds/artifact/18/Implementation_Guide_CDS_Connect_Statin_CVD_Clinician_Facing_0.pdf
September 01, 2022 - structured (i.e., coded) version of the PCE entitled CMS’s
Million Hearts® Model Longitudinal ASCVD Risk Assessment … Inclusions “Within the past 6
years”
The ACC/AHA recommends assessment of ASCVD risk every 4–6 years … Because
lipid profile results and smoking status are inputs to ASCVD risk assessment, the CDS Connect … Cardiovascular Preventive Therapies Among Medicare Patients: The Million
Hearts Longitudinal ASCVD Risk Assessment … CMS’s Million Hearts® Model Longitudinal ASCVD Risk
Assessment Tool for Baseline 10-Year ASCVD Risk
-
cds.ahrq.gov/sites/default/files/cds/artifact/18/2023_CDS_Connect_IG_Statin_CVD_Clinician_Facing.pdf
January 01, 2023 - structured (i.e., coded) version of the PCE entitled CMS’s
Million Hearts® Model Longitudinal ASCVD Risk Assessment … Inclusions “Within the past 6
years”
The ACC/AHA recommends assessment of ASCVD risk every 4 – 6 years … Because
lipid profile results and smoking status are inputs to ASCVD risk assessment, the CDS Connect … Cardiovascular Preventive Therapies Among Medicare Patients: The Million
Hearts Longitudinal ASCVD Risk Assessment … CMS’s Million Hearts® Model Longitudinal ASCVD Risk
Assessment Tool for Baseline 10-Year ASCVD Risk
-
cds.ahrq.gov/sites/default/files/cds/artifact/18/2024_CDS_Connect_IG_Statin_CVD_Clinician_Facing.pdf
January 01, 2024 - i.e., coded) version of the 2013 PCE,
entitled CMS’s Million Hearts® Model Longitudinal ASCVD Risk Assessment … Concept Definition and/or Rationale
Inclusions “Within the past 6
years”
The ACC/AHA recommends assessment … Because lipid profile results and smoking status are inputs to ASCVD risk assessment, the CDS
Connect … resource that is publicly available in the CDS Connect Million Hearts
Model Longitudinal ASCVD Risk Assessment … CMS’s Million Hearts® Model Longitudinal ASCVD Risk
Assessment Tool for Baseline 10-Year ASCVD Risk
-
cds.ahrq.gov/sites/default/files/cds/artifact/1056/2024_CDS_Connect_IG_Statin_CVD_Patient_Facing_2.pdf
January 01, 2024 - i.e., coded) version of the 2013 PCE,
entitled CMS’s Million Hearts® Model Longitudinal ASCVD Risk Assessment … supplemented by enabling data collection directly from the patient through an
automated form, risk assessment … Inclusions “Within the past 6 years” The ACC/AHA recommends assessment of ASCVD risk every four to six … Because lipid profile results and
smoking status are inputs to ASCVD risk assessment, the CDS Connect … CMS’s Million Hearts® Model Longitudinal ASCVD Risk
Assessment Tool for Baseline 10-Year ASCVD Risk
-
cds.ahrq.gov/sites/default/files/cds/artifact/logic/2023-08/StatinTherapyForThePreventionAndTreatmentOfCVDeCQMDerived_Change_Log_0.txt
January 01, 2023 - added Hospice care [Minimum Data Set]
- Codes: added Yes (qualifier value)
- Codes: added Functional Assessment … added Hospice care [Minimum Data Set]
- Codes: added Yes (qualifier value)
- Codes: added Functional Assessment
-
cds.ahrq.gov/sites/default/files/workgroups/28166/CDS_Connect_WG_Slides_August%202021.pdf
August 01, 2021 - logic for the following artifacts (in progress):
− CMS’s Million Hearts® Model Longitudinal ASCVD Risk Assessment
-
cds.ahrq.gov/sites/default/files/cds/artifact/18/Implementation%20Guide_Statin%20Use%20for%20CVD%20Prevention%20in%20Adults_Clinician%20Facing%20CDS%20Intervention.pdf
January 01, 2020 - structured (i.e., coded) version of the PCE entitled CMS’s
Million Hearts® Model Longitudinal ASCVD Risk Assessment … https://cds.ahrq.gov/cdsconnect/artifact/cmss-million-heartsr-model-longitudinal-ascvd-risk-assessment-tool-baseline … Inclusions “within the past 6
years”
The ACC/AHA recommends assessment of ASCVD risk every 4 – 6 years … Since lipid profile results and smoking status are inputs to ASCVD risk
assessment, the CDS Connect … CMS’s Million Hearts® Model Longitudinal ASCVD Risk
Assessment Tool for Baseline 10-Year ASCVD Risk